Specialized cells in the human body make biological trade-offs to perform certain jobs. To support the large, hardworking hearts that power other organs, heart cells have evolved to be extremely ...
Off-the-shelf and mass-producible immune cells fight solid human tumors engrafted in mice. The Kobe University development is ...
iXCells Biotechnologies ("iXCells"), a leading provider of human cell-based solutions and custom iPSC services, today announced it has entered an international collaboration with Rosebud Biosciences ( ...
Joint initiative with Rosebud Biosciences, Kantify, and funded by Incite will identify and quantify off-target toxicities in chemotherapy patients Development of patient-specific human organoids ...
Organoids, as near-physiological 3D culture systems, offer new opportunities to study the pathogenesis of various organs in mimicking the cellular complexity and functionality of human organs.
aInstitute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan bDepartment of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National ...
The ectopic expression of four transcription factors, Oct3/4, Sox2, Klf4, and c-Myc (OSKM), known as “Yamanaka factors,” can reprogram or stimulate the production of induced pluripotent stem cells ...
Following a one medicine approach, the development of regenerative therapies for human patients leads to innovative treatments for animals, while pre-clinical studies on animals provide knowledge to ...
Creative Commons (CC): This is a Creative Commons license. Attribution (BY): Credit must be given to the creator. CRISPR-Cas12a nucleases have expanded the toolbox for targeted genome engineering in a ...
aKoch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA bDepartment of Cancer Immunology and Virology, Dana-Farber ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results